234 related articles for article (PubMed ID: 14980612)
1. Convenient synthesis and evaluation of glycosidase inhibitory activity of alpha- and beta-galactose-type valienamines, and some N-alkyl derivatives.
Ogawa S; Sakata Y; Ito N; Watanabe M; Kabayama K; Itoh M; Korenaga T
Bioorg Med Chem; 2004 Mar; 12(5):995-1002. PubMed ID: 14980612
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and glycosidase inhibitory activity of some N-substituted 5a-carba-beta-fuco- and beta-galactopyranosylamines, and selected derivatives.
Ogawa S; Fujieda S; Sakata Y; Ishizaki M; Hisamatsu S; Okazaki K; Ooki Y; Mori M; Itoh M; Korenaga T
Bioorg Med Chem; 2004 Dec; 12(24):6569-79. PubMed ID: 15556773
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 5a-carba-hexopyranoses and hexopyranosylamines, as well as 5a,5a'-dicarbadisaccharides, from 3,8-dioxatricyclo[4.2.1.0(2,4)]nonan-9-ol: glycosidase inhibitory activity of N-substituted 5a-carba-beta-gluco- and beta-galactopyranosylamines, and derivatives thereof.
Ogawa S; Funayama S; Okazaki K; Ishizuka F; Sakata Y; Doi F
Bioorg Med Chem Lett; 2004 Oct; 14(20):5183-8. PubMed ID: 15380224
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of glycosidase inhibitor 5-amino-1,2,3,4-cyclohexanetetrol derivatives from (-)-vibo-quercitol.
Ogawa S; Asada M; Ooki Y; Mori M; Itoh M; Korenaga T
Bioorg Med Chem; 2005 Jul; 13(13):4306-14. PubMed ID: 15878669
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of an alpha-fucosidase inhibitor, 5a-carba-beta-L-fucopyranosylamine, and fucose-type alpha- and beta-DL-valienamine unsaturated derivatives.
Ogawa S; Watanabe M; Maruyama A; Hisamatsu S
Bioorg Med Chem Lett; 2002 Mar; 12(5):749-52. PubMed ID: 11858994
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of alpha-fucosidase inhibitory activity of 5a-carba-alpha-L-fucopyranose and alpha-DL-fucopyranosylamine.
Ogawa S; Sekura R; Maruyama A; Odagiri T; Yuasa H; Hashimoto H
Carbohydr Lett; 2000; 4(1):13-20. PubMed ID: 11469333
[TBL] [Abstract][Full Text] [Related]
7. Search for alpha-glucosidase inhibitors: new N-substituted valienamine and conduramine F-1 derivatives.
Łysek R; Schütz C; Favre S; O'Sullivan AC; Pillonel C; Krülle T; Jung PM; Clotet-Codina I; Esté JA; Vogel P
Bioorg Med Chem; 2006 Sep; 14(18):6255-82. PubMed ID: 16797996
[TBL] [Abstract][Full Text] [Related]
8. Transformation of quercitols into 4-methylenecyclohex-5-ene-1,2,3-triol derivatives, precursors for the chemical chaperones N-octyl-4-epi-β-valienamine (NOEV) and N-octyl-β-valienamine (NOV).
Kuno S; Takahashi A; Ogawa S
Bioorg Med Chem Lett; 2011 Dec; 21(23):7189-92. PubMed ID: 22001090
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of iminoalditol analogues of galactofuranosides and their activities against glycosidases.
Sandbhor M; Bhasin M; Williams DT; Hsieh M; Wu SH; Zou W
Carbohydr Res; 2008 Nov; 343(17):2878-86. PubMed ID: 18706536
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 5a-carbaglycopyranosylamime glycosidase inhibitors.
Ogawa S; Kanto M
Curr Top Med Chem; 2009; 9(1):58-75. PubMed ID: 19199996
[TBL] [Abstract][Full Text] [Related]
11. Thiodisaccharides with galactofuranose or arabinofuranose as terminal units: synthesis and inhibitory activity of an exo beta-D-galactofuranosidase.
Repetto E; Marino C; Uhrig ML; Varela O
Bioorg Med Chem; 2009 Apr; 17(7):2703-11. PubMed ID: 19282191
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and glycosidase inhibitory profiles of functionalised morpholines and oxazepanes.
Burland PA; Osborn HM; Turkson A
Bioorg Med Chem; 2011 Sep; 19(18):5679-92. PubMed ID: 21862336
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of both enantiomers of hydroxypipecolic acid derivatives equivalent to 5-azapyranuronic acids and evaluation of their inhibitory activities against glycosidases.
Yoshimura Y; Ohara C; Imahori T; Saito Y; Kato A; Miyauchi S; Adachi I; Takahata H
Bioorg Med Chem; 2008 Sep; 16(17):8273-86. PubMed ID: 18703340
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and glycosidase inhibitory activity of 1-amino-3,6-anhydro-1-deoxy-D-sorbitol derivatives.
Guillarme S; Behr JB; Bello C; Vogel P; Saluzzo C
Bioorg Chem; 2010 Apr; 38(2):43-7. PubMed ID: 20060997
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and α-Glucosidase II inhibitory activity of valienamine pseudodisaccharides relevant to N-glycan biosynthesis.
Cumpstey I; Ramstadius C; Eszter Borbas K; Alonzi DS; Butters TD
Bioorg Med Chem Lett; 2011 Sep; 21(18):5219-23. PubMed ID: 21840710
[TBL] [Abstract][Full Text] [Related]
16. Convenient synthesis and evaluation of enzyme inhibitory activity of several N-alkyl-, N-phenylalkyl, and cyclic isourea derivatives of 5a-carba-alpha-DL-fucopyranosylamine.
Ogawa S; Mori M; Takeuchi G; Doi F; Watanabe M; Sakata Y
Bioorg Med Chem Lett; 2002 Oct; 12(20):2811-4. PubMed ID: 12270152
[TBL] [Abstract][Full Text] [Related]
17. Chemical modification of the beta-glucocerebrosidase inhibitor N-octyl-beta-valienamine: synthesis and biological evaluation of 4-epimeric and 4-O-(beta-D-galactopyranosyl) derivatives.
Ogawa S; Matsunaga YK; Suzuki Y
Bioorg Med Chem; 2002 Jun; 10(6):1967-72. PubMed ID: 11937356
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of an ether-linked alkyl 5a-carba-beta-D-glucoside, a 5a-carba-beta-D-galactoside, a 2-acetamido-2-deoxy-5a-carba-beta-D-glucoside, and an alkyl 5a'-carba-beta-lactoside.
Ogawa S; Aoyama H; Sato T
Carbohydr Res; 2002 Nov; 337(21-23):1979-92. PubMed ID: 12433463
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of glycosidase inhibitory activity of N-butyl 1-deoxy-D-gluco-homonojirimycin and N-butyl 1-deoxy-L-ido-homonojirimycin.
Markad SD; Karanjule NS; Sharma T; Sabharwal SG; Dhavale DD
Bioorg Med Chem; 2006 Aug; 14(16):5535-9. PubMed ID: 16682208
[TBL] [Abstract][Full Text] [Related]
20. Alpha-1-C-alkyl-1-deoxynojirimycin derivatives as potent and selective inhibitors of intestinal isomaltase: remarkable effect of the alkyl chain length on glycosidase inhibitory profile.
Godin G; Compain P; Martin OR; Ikeda K; Yu L; Asano N
Bioorg Med Chem Lett; 2004 Dec; 14(24):5991-5. PubMed ID: 15546715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
